Use of ceftazidime/avibactam for the treatment of MDR Pseudomonas aeruginosa and Burkholderia cepacia complex infections in cystic fibrosis: a case series-Reference-Cited by-同舟云学术

Use of ceftazidime/avibactam for the treatment of MDR Pseudomonas aeruginosa and Burkholderia cepacia complex infections in cystic fibrosis: a case series

Published:2019-01-11 Issue:5 Volume:74 Page:1425-1429
ISSN:0305-7453
Container-title:Journal of Antimicrobial Chemotherapy
language:en
Short-container-title:

Author:

Spoletini G¹²^ORCID,Etherington C¹,Shaw N¹,Clifton I J¹,Denton M¹³,Whitaker P¹,Peckham D G¹²

Affiliation:

1. The Leeds Regional Adult Cystic Fibrosis Centre, St James’s University Hospital, Leeds Teaching Hospital NHS Trust, Leeds, UK

2. Leeds Institute of Medical Research, University of Leeds, Leeds, UK

3. Department of Microbiology, Leeds General Infirmary, Leeds Teaching Hospital NHS Trust, Leeds, UK

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)

Link

http://academic.oup.com/jac/article-pdf/74/5/1425/28501242/dky558.pdf

Reference22 articles.

1. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis;Emerson;Pediatr Pulmonol,2002

2. Clinical outcome of Burkholderia cepacia complex infection in cystic fibrosis adults;Courtney;J Cyst Fibros,2004

3. Fosfomycin therapy for multiresistant Pseudomonas aeruginosa in cystic fibrosis;Mirakhur;J Cyst Fibros,2003

4. Intravenous fosfomycin for pulmonary exacerbation of cystic fibrosis: real life experience of a large adult CF centre;Spoletini;Pulm Pharmacol Ther,2018

5. Ceftazidime-avibactam: an evidence-based review of its pharmacology and potential use in the treatment of Gram-negative bacterial infections;Lagacé-Wiens;Core Evid,2014

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolving resistance landscape in gram‐negative pathogens: An update on β‐lactam and β‐lactam‐inhibitor treatment combinations for carbapenem‐resistant organisms;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-07

2. Novel Approaches to Multidrug-Resistant Infections in Cystic Fibrosis;Infectious Disease Clinics of North America;2024-03

3. Burkholderia vietnamiensis Causing Bacteremia in Patients Suffering from B-Cell Acute Lymphocytic Leukemia: A Case Series and Review of Literature;Journal of Laboratory Physicians;2023-10-03

4. Profiling cell envelope-antibiotic interactions reveals vulnerabilities to β-lactams in a multidrug-resistant bacterium;Nature Communications;2023-08-09

5. Phage therapy in a lung transplant recipient with cystic fibrosis infected with multidrug‐resistant Burkholderia multivorans;Transplant Infectious Disease;2023-03-02